ID27845A - Turunan tetrahidrokuilina sebagai antagonis glisilina - Google Patents
Turunan tetrahidrokuilina sebagai antagonis glisilinaInfo
- Publication number
- ID27845A ID27845A IDW20010061A ID20010061A ID27845A ID 27845 A ID27845 A ID 27845A ID W20010061 A IDW20010061 A ID W20010061A ID 20010061 A ID20010061 A ID 20010061A ID 27845 A ID27845 A ID 27845A
- Authority
- ID
- Indonesia
- Prior art keywords
- tetrahidrokuilina
- glisilina
- antagonists
- decreased
- tetrahidrokuilina decreased
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 230000003247 decreasing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9812408.4A GB9812408D0 (en) | 1998-06-10 | 1998-06-10 | Heterocyclic compounds |
| GBGB9812410.0A GB9812410D0 (en) | 1998-06-10 | 1998-06-10 | Heterocyclic derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID27845A true ID27845A (id) | 2001-04-26 |
Family
ID=26313826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20010061A ID27845A (id) | 1998-06-10 | 1999-06-08 | Turunan tetrahidrokuilina sebagai antagonis glisilina |
Country Status (34)
| Country | Link |
|---|---|
| US (3) | US6362199B1 (id) |
| EP (1) | EP1086093B1 (id) |
| JP (1) | JP2002517492A (id) |
| KR (1) | KR100586762B1 (id) |
| CN (1) | CN1173970C (id) |
| AP (1) | AP2000002008A0 (id) |
| AR (1) | AR018632A1 (id) |
| AT (1) | ATE301650T1 (id) |
| AU (1) | AU753867B2 (id) |
| BG (1) | BG105123A (id) |
| BR (1) | BR9911145A (id) |
| CA (1) | CA2334727C (id) |
| CO (1) | CO5080785A1 (id) |
| CZ (1) | CZ293605B6 (id) |
| DE (1) | DE69926632T2 (id) |
| DK (1) | DK1086093T3 (id) |
| EA (1) | EA003276B1 (id) |
| EE (1) | EE200000733A (id) |
| ES (1) | ES2249010T3 (id) |
| HK (1) | HK1034079A1 (id) |
| HR (1) | HRP20000845A2 (id) |
| HU (1) | HUP0102767A3 (id) |
| ID (1) | ID27845A (id) |
| IL (2) | IL140062A0 (id) |
| IS (1) | IS5746A (id) |
| MY (1) | MY125037A (id) |
| NO (1) | NO321904B1 (id) |
| NZ (1) | NZ508638A (id) |
| OA (1) | OA11564A (id) |
| PE (1) | PE20000724A1 (id) |
| PL (1) | PL197160B1 (id) |
| TR (1) | TR200003652T2 (id) |
| TW (1) | TWI229079B (id) |
| WO (1) | WO1999064411A1 (id) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY125037A (en) * | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
| US6455734B1 (en) * | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| GB9929037D0 (en) * | 1999-12-08 | 2000-02-02 | Glaxo Wellcome Spa | Heterocyclic derivatives |
| DE10000311A1 (de) | 2000-01-05 | 2001-07-12 | Gruenenthal Gmbh | Aminomethyl-Phonyl-Cyclohexanonderivate |
| DE10005302A1 (de) * | 2000-02-07 | 2002-01-17 | Gruenenthal Gmbh | Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate |
| DE10137488A1 (de) * | 2001-08-03 | 2003-02-20 | Gruenenthal Gmbh | Salze substituierter 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate |
| DE10137487A1 (de) * | 2001-08-03 | 2003-03-27 | Gruenenthal Gmbh | Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate |
| US20090181966A1 (en) * | 2002-10-04 | 2009-07-16 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
| AU2003277285B2 (en) * | 2002-10-04 | 2007-12-13 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
| US7504508B2 (en) * | 2002-10-04 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
| GB0327912D0 (en) * | 2003-12-02 | 2004-01-07 | Glaxo Group Ltd | Medicament |
| WO2006091674A1 (en) * | 2005-02-24 | 2006-08-31 | Millennium Pharmaceuticals, Inc. | Pgd2 receptor antagonists for the treatment of inflammatory diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2024516C1 (ru) * | 1989-02-02 | 1994-12-15 | Яманути Фармасьютикал Ко., Лтд. | Способ получения производного тетрагидробензимидазола или его фармацевтически приемлемой соли |
| US4902695A (en) * | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| EP0386839B1 (en) * | 1989-03-08 | 1997-01-15 | Merck Sharp & Dohme Ltd. | Tetrahydroquinoline derivatives useful for neurodegenerative disorders |
| US5231102A (en) * | 1989-03-08 | 1993-07-27 | Merck Sharp & Dohme, Ltd. | Tetrahydroquinoline derivatives useful for neurodegenerative disorders |
| US5529999A (en) | 1994-03-04 | 1996-06-25 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| TR199800531T1 (xx) | 1995-09-29 | 1998-06-22 | Glaxo Wellcome Spa | NMDA antagonistleri olarak tetrahidrokinolinler. |
| GB9617305D0 (en) * | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
| MY125037A (en) * | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
-
1999
- 1999-06-07 MY MYPI99002298A patent/MY125037A/en unknown
- 1999-06-08 PE PE1999000511A patent/PE20000724A1/es not_active Application Discontinuation
- 1999-06-08 EP EP99927911A patent/EP1086093B1/en not_active Expired - Lifetime
- 1999-06-08 DK DK99927911T patent/DK1086093T3/da active
- 1999-06-08 AU AU45092/99A patent/AU753867B2/en not_active Ceased
- 1999-06-08 WO PCT/EP1999/003936 patent/WO1999064411A1/en active IP Right Grant
- 1999-06-08 CN CNB998094145A patent/CN1173970C/zh not_active Expired - Fee Related
- 1999-06-08 JP JP2000553420A patent/JP2002517492A/ja active Pending
- 1999-06-08 EE EEP200000733A patent/EE200000733A/xx unknown
- 1999-06-08 AT AT99927911T patent/ATE301650T1/de active
- 1999-06-08 US US09/719,188 patent/US6362199B1/en not_active Expired - Fee Related
- 1999-06-08 ID IDW20010061A patent/ID27845A/id unknown
- 1999-06-08 TR TR2000/03652T patent/TR200003652T2/xx unknown
- 1999-06-08 NZ NZ508638A patent/NZ508638A/en not_active IP Right Cessation
- 1999-06-08 KR KR1020007013994A patent/KR100586762B1/ko not_active IP Right Cessation
- 1999-06-08 CZ CZ20004587A patent/CZ293605B6/cs not_active IP Right Cessation
- 1999-06-08 BR BR9911145-4A patent/BR9911145A/pt not_active Application Discontinuation
- 1999-06-08 PL PL344694A patent/PL197160B1/pl not_active IP Right Cessation
- 1999-06-08 CO CO99035699A patent/CO5080785A1/es unknown
- 1999-06-08 DE DE69926632T patent/DE69926632T2/de not_active Expired - Lifetime
- 1999-06-08 HU HU0102767A patent/HUP0102767A3/hu unknown
- 1999-06-08 AR ARP990102714A patent/AR018632A1/es active IP Right Grant
- 1999-06-08 OA OA1200000335A patent/OA11564A/en unknown
- 1999-06-08 EA EA200001165A patent/EA003276B1/ru not_active IP Right Cessation
- 1999-06-08 IL IL14006299A patent/IL140062A0/xx active IP Right Grant
- 1999-06-08 CA CA002334727A patent/CA2334727C/en not_active Expired - Fee Related
- 1999-06-08 AP APAP/P/2000/002008A patent/AP2000002008A0/en unknown
- 1999-06-08 ES ES99927911T patent/ES2249010T3/es not_active Expired - Lifetime
- 1999-06-17 TW TW088110159A patent/TWI229079B/zh not_active IP Right Cessation
-
2000
- 2000-11-30 IS IS5746A patent/IS5746A/is unknown
- 2000-12-04 IL IL140062A patent/IL140062A/en not_active IP Right Cessation
- 2000-12-07 NO NO20006227A patent/NO321904B1/no not_active IP Right Cessation
- 2000-12-08 HR HR20000845A patent/HRP20000845A2/hr not_active Application Discontinuation
-
2001
- 2001-01-08 BG BG105123A patent/BG105123A/xx unknown
- 2001-07-03 HK HK01104579A patent/HK1034079A1/xx not_active IP Right Cessation
- 2001-11-16 US US09/990,513 patent/US6413985B1/en not_active Expired - Fee Related
-
2002
- 2002-05-14 US US10/145,258 patent/US6495566B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20016115L (no) | Substituerte heterosykelkondenserte gamma-karbolin | |
| PT1224180E (pt) | Azois substituidos | |
| ID29066A (id) | Turunan fenilglisina | |
| ID27423A (id) | Turunan kuinolin | |
| ID23234A (id) | Turunan-turunan benzosulfona | |
| ID27484A (id) | Turunan adenosina | |
| FI4209U1 (fi) | Uusia yhdisteitä | |
| NO990113D0 (no) | Flerskrog-fart°y | |
| ID27547A (id) | Turunan kuinolin | |
| ID23287A (id) | Trisiklik tersubstitusi | |
| NO992692D0 (no) | Nefadozon doseringsform | |
| NO994626D0 (no) | Substituerte benzamider | |
| EE200000171A (et) | Uued NPY antagonistid | |
| ID26223A (id) | Antagonis reseptor vitronektin | |
| ID26665A (id) | Antagonis vla-4 | |
| ID29914A (id) | Senyawa benzensulfonamida heterosiklik sebagai antagonis bradikinin | |
| NO20010873L (no) | Mikropartikkel-blanding | |
| ID22838A (id) | Oksazolidina sebagai antagonis 5-ht2a | |
| ID23219A (id) | Trisiklik tersubstitusi | |
| ID27845A (id) | Turunan tetrahidrokuilina sebagai antagonis glisilina | |
| ID28811A (id) | Antagonis reseptor vitronektin | |
| ID28356A (id) | Turunam tiazola | |
| NO20022927L (no) | Substituerte pyrrazoler | |
| ID26508A (id) | Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin | |
| DE59912188D1 (de) | Substituierte phenyluracile |